tiprankstipranks
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
US Market

BridgeBio Pharma (BBIO) Income Statement

Compare
1,148 Followers

BridgeBio Pharma Income Statement

Last quarter (Q3 2024), BridgeBio Pharma's total revenue was $2.73M, a decrease of -33.22% from the same quarter last year. In Q3, BridgeBio Pharma's net income was $-162.04M. See BridgeBio Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 9.30M$ 77.65M$ 69.72M$ 8.25M$ 40.56M
Gross Profit
$ 6.86M$ 74.21M$ 66.60M$ 5.16M$ 38.06M
Operating Expenses
$ 614.23M$ 546.09M$ 646.35M$ 482.73M$ 304.30M
Depreciation and Amortization
$ 6.49M$ 6.77M$ 5.84M$ 3.09M$ 859.00K
EBITDA
$ -565.47M$ -397.44M$ -533.83M$ -465.75M$ -279.82M
Operating Income
$ -607.37M$ -471.87M$ -579.75M$ -474.48M$ -266.24M
Other Income/Expenses
$ -45.88M$ 27.55M$ -9.82M$ -31.01M$ -22.34M
Pretax Income
$ -653.25M$ -484.65M$ -586.45M$ -505.49M$ -288.58M
Net Income
$ -643.20M$ -493.96M$ -639.30M$ -483.93M$ -260.44M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.95$ -3.35$ -4.43$ -4.10$ -2.48
Diluted EPS
$ -3.95$ -3.35$ -4.43$ -4.10$ -2.48
Weighted Average Shares Outstanding
162.79M 147.47M 144.36M 118.00M 105.10M
Weighted Average Shares Outstanding (Diluted)
162.79M 147.47M 144.36M 118.00M 105.10M
Currency in USD

BridgeBio Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis